The newborn mouse tumorigenicity assay, which reached 155.1 1 10 06 following a cumulative dose involves the treatment of animals during the first two of 49 mg ENU/kg body weight and 172.3 1 10 06 weeks after birth and monitoring tumor induction following a cumulative dose of 142 mg ENU/kg. after a
Transplacental mutagenicity of N-ethyl-N-nitrosourea at the hprt locus in T-lymphocytes of exposed B6C3F1 mice
โ Scribed by Hillary E. Sussman; Michael J. Bauer; Xiaochu Shi; Stephen A. Judice; Richard J. Albertini; Vernon E. Walker
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 100 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0893-6692
- DOI
- 10.1002/em.1047
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The relative sensitivities and specificities of the endogenous Hprt gene and the lacI transgene as mutational targets were evaluated in splenic lymphocytes from male standard B6C3F1 mice (only Hprt assayed) and from lacI transgenic B6C3F1 mice treated at 6 -7 weeks-of-age with the indirectacting age
The endogenous, autosomal Tk gene is a potentially useful reporter of in vivo mutation since it may recover a wider range of mutational events than the X-linked Hprt gene or bacterial transgenes. In this study, we characterized mutations produced in the Tk gene of Tk ฯฉ/ฯช mice and compared them with
Big Blue@ (BB) and generic B6C3F1 mice were given one to three i.p. injections of 50 mg/kg benzo[a]pyrene (B[a]P) in DMSO every other day to achieve cumulative doses of 50 to 150 mg/kg. Three weeks after treatment, the mutation frequency at the endogenous hprt gene and lac/ transgene was measured in